Online inquiry

IVTScrip™ mRNA-Human AGMO, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK20104MR)

This product GTTS-WK20104MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 1 & N1-Methylpseudo-UTP. It ecodes the AGMO protein. This product can be used in Mitotic arrest phase fetal germ cell-related researches.
Specifications
Product type mRNA
Modified bases N1-Methylpseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_001004320.2
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 392636
UniProt ID Q6ZNB7
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human AGMO, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) (GTTS-WK20104MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK18613MR IVTScrip™ mRNA-Human AGPAT9, (Cap 1, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA AGPAT9
GTTS-WK21097MR IVTScrip™ mRNA-Human ALDH1L1, (Cap 1, 5-Methyl-CTP, 30 nt-poly(A)) mRNA ALDH1L1
GTTS-WK9404MR IVTScrip™ mRNA-Human ACAD10, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ACAD10
GTTS-WK7040MR IVTScrip™ mRNA-Human CRYL1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA CRYL1
GTTS-WK16967MR IVTScrip™ mRNA-Human ANAPC1, (Cap 0, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA ANAPC1
GTTS-WK22167MR IVTScrip™ mRNA-Human ATL2, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ATL2
GTTS-WK1330MR IVTScrip™ mRNA-Human Carboxypeptidase M, (Cap 0, 5-Methyl-CTP, 120 nt-poly(A)) mRNA Carboxypeptidase M
GTTS-WK14792MR IVTScrip™ mRNA-Human Aldehyde Dehydrogenase 1-A1, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA Aldehyde Dehydrogenase 1-A1
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW